Evidence map›Paper›PMID 21684831›Full record

ReviewEnvironmental health perspectives2011

Arsenic toxicology: translating between experimental models and human pathology.

J Christopher States, Aaron Barchowsky, Iain L Cartwright, John F Reichard, Bernard W Futscher, R Clark Lantz

Abstract readReview
In one paragraph

Review in Environmental health perspectives, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Arsenic-induced prostate cancer: an enigma.Medical oncology (Northwood, London, England) · 2024
    Review
  6. Article
  7. Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  8. Article
  9. Article
  10. Structural and functional mapping ofComputational and structural biotechnology journal · 2023
    Article
  11. miRNAs and arsenic-induced carcinogenesis.Advances in pharmacology (San Diego, Calif.) · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J Christopher StatesDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky, USA. jcstates@louisville.edu
Aaron Barchowsky
Iain L Cartwright
John F Reichard
Bernard W Futscher
R Clark Lantz

Funding

TRANSPORT OF TRACE METALS IN A POLLUTED AQUIFERP42ES004940 · NIEHS · UNIVERSITY OF ARIZONA · PI Bernardo Lemos · 1990 to 2026
$68.1M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
MOLECULAR MECHANISMS OF COMPLEX MIXTURE TOXICITYR01ES010807 · NIEHS · UNIVERSITY OF CINCINNATI · PI PUGA, ALVARO · 2001 to 2021
$8.0M
Strategic Vision & Impact on Environmental HealthP30ES014443 · NIEHS · UNIVERSITY OF LOUISVILLE · PI LI, YONG · 2007 to 2010
$4.4M
Mechanisms for Arsenic-Induced Vascular DiseaseR01ES013781 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BARCHOWSKY, AARON · 2008 to 2012
$2.5M
Transplacental Arsenic Induced Hepatic Dysfunction and Vascular DiseaseR21ES015812 · NIEHS · UNIVERSITY OF LOUISVILLE · PI STATES, J CHRISTOPHER · 2008 to 2010
$417k
Exploring arsenic and its metabolites in a transgenic modelR21ES017235 · NIEHS · UNIVERSITY OF CINCINNATI · PI CARTWRIGHT, IAIN L · 2009 to 2010
$406k
NIEHS NIH HHS P30 ES006096NIEHS NIH HHS P30ES006096NIEHS NIH HHS P30 ES006694NIEHS NIH HHS P30ES006694NIEHS NIH HHS P30 ES014443NIEHS NIH HHS P30ES014443NIEHS NIH HHS P42 ES004940NIEHS NIH HHS P42ES004940NIEHS NIH HHS R01 ES010807NIEHS NIH HHS R01ES010807NIEHS NIH HHS R01 ES013781NIEHS NIH HHS R01ES013781-02S1NIEHS NIH HHS R21ES01581NIEHS NIH HHS R21 ES015812NIEHS NIH HHS R21ES015812-02S2NIEHS NIH HHS R21 ES017235NIEHS NIH HHS R21ES017235
6 · The paper itself

Abstract

backgroundChronic arsenic exposure is a worldwide health problem. How arsenic exposure promotes a variety of diseases is poorly understood, and specific relationships between experimental and human exposures are not established. We propose phenotypic anchoring as a means to unify experimental observations and disease outcomes.

objectivesWe examined the use of phenotypic anchors to translate experimental data to human pathology and investigated research needs for which phenotypic anchors need to be developed.

methodsDuring a workshop, we discussed experimental systems investigating arsenic dose/exposure and phenotypic expression relationships and human disease responses to chronic arsenic exposure and identified knowledge gaps. In a literature review, we identified areas where data exist to support phenotypic anchoring of experimental results to pathologies from specific human exposures. DISCUSSION: Disease outcome is likely dependent on cell-type-specific responses and interaction with individual genetics, other toxicants, and infectious agents. Potential phenotypic anchors include target tissue dosimetry, gene expression and epigenetic profiles, and tissue biomarkers.

conclusionsTranslation to human populations requires more extensive profiling of human samples along with high-quality dosimetry. Anchoring results by gene expression and epigenetic profiling has great promise for data unification. Genetic predisposition of individuals affects disease outcome. Interactions with infectious agents, particularly viruses, may explain some species-specific differences between human pathologies and experimental animal pathologies. Invertebrate systems amenable to genetic manipulation offer potential for elaborating impacts of specific biochemical pathways. Anchoring experimental results to specific human exposures will accelerate understanding of mechanisms of arsenic-induced human disease.

Indexed as

AnimalsArsenicFemaleHumansMaleModels, TheoreticalPregnancyArsenic

Identifiers

PMID21684831
PMCPMC3230447

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.